Over in Grant, the Tennessee Valley Authority awarded funding to a science class at Kate Duncan Smith DAR Middle School to ...
Biotech investors often chase early-stage companies in the hope that a single breakthrough trial will deliver massive returns ...
SHANGHAI, Feb 6 (Reuters) - Japan's Eisai will licence Shanghai Henlius Biotech's lung cancer drug Hansizhuang, paying $75 ...
EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the ...
The deal is structured to provide immediate fiscal returns, with a portion of the nine-figure commitment serving as direct ...
Eikon Therapeutics increased the size of its initial public offering at the last minute and priced at the top of its range, ...
Life sciences leaders in Boston are increasingly concerned that the "millionaires tax" is driving away founders and investors ...
Feb 4 (Reuters) - Biotech firm PrimeGen US will go public in the United States through a $1.5 billion deal with blank-check ...
A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics on Monday in Delaware federal court, ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Legend Biotech Corp (NASDAQ:LEGN) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. In a board shakeup last month, Legend Biotech Corp (NASDAQ:LEGN) appointed chairman and executive ...
Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results